Afyx Therapeutics A/S

CVR 38793594 · Public limited company (A/S) · Active · Low risk

Afyx Therapeutics A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 36.2m and a net result of DKK 1.5m.

Bankruptcy risk for Afyx Therapeutics A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38793594
Status
Active
Company type
Public limited company (A/S)
Founded
(9 years)
Address
Slotsmarken 11
2970 Hørsholm
Municipality
Hørsholm
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 20.0m
Employees
1 (2018)
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late3 of 8
Missing annual reportNo
Negative equityNo
Equity ratio88.5%
Current ratio823%
Moves (last 2 years)1
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address22
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 23.1mDKK 23.5mDKK 11.2m
Net profitDKK 1.5mDKK -3.8mDKK -982k
EquityDKK 36.2mDKK 9.7mDKK -794k
Total assetsDKK 40.9mDKK 15.5mDKK 10.3m
CashDKK 13.0mDKK 1.5m–
Short-term debtDKK 4.7mDKK 5.8m–
Avg. employees511–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025183
1 Jan 2024 – 31 Dec 2024147
1 Jan 2023 – 31 Dec 2023107
1 Jan 2022 – 31 Dec 2022142
1 Jan 2021 – 31 Dec 2021179
1 Jan 2020 – 31 Dec 2020126
1 Jan 2019 – 31 Dec 2019251 Late
12 Jul 2017 – 31 Dec 2018185 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEORichard Henry Poulsen
BoardOle BaadsgaardCurrent
BoardClaus Juan Møller-San PedroCurrent
BoardPia Leah Møller-San PedroCurrent
BoardSøren Mohrsen KjærCurrent
BoardSøren Anker Nielsen
BoardClaus Juan Møller-San Pedro
BoardSøren Anker Nielsen
Owner (67%)Afyx Capital ApSCurrent
Owner (50%)JUUZ ApS
Owner (50%)Afyx Capital ApS
Owner (25%)JUUZ ApS
Owner (25%)INVESTERINGSSELSKABET GH ApS
Owner (25%)Afyx Capital ApS
Owner (5%)Michael Rimikis
Owner (5%)Richard Henry Poulsen
Owner (25%)JUUZ ApS
Owner (25%)INVESTERINGSSELSKABET GH ApS
Owner (25%)Afyx Capital ApS
Owner (33%)Afyx Capital ApS
Owner (15%)Søren Anker Nielsen
Owner (15%)Bo Kruse
Owner (15%)JUUZ ApS
Owner (15%)INVESTERINGSSELSKABET GH ApS
Owner (50%)Afyx Capital ApS
Owner (25%)Søren Anker Nielsen
Owner (5%)Bo Kruse
Owner (25%)JUUZ ApS
Owner (5%)INVESTERINGSSELSKABET GH ApS
Owner (25%)JUUZ ApS
Owner (5%)INVESTERINGSSELSKABET GH ApS
Owner (50%)Afyx Capital ApS
Owner (20%)INVESTERINGSSELSKABET GH ApS
Owner (50%)Afyx Capital ApS
Owner (5%)JUUZ ApS
Owner (5%)INVESTERINGSSELSKABET GH ApS
Owner (67%)Afyx Capital ApS
Owner (5%)SPEXMAC HOLDING ApS
Owner (50%)Afyx Capital ApS
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorGILFELT REVISION REGISTRERET REVISIONSANPARTSSELSKAB
FounderJUUZ ApSCurrent
FounderAfyx Capital ApSCurrent

The CEOs' other companies

Richard Henry Poulsen – 2 other companies

Address history (2 moves)

Slotsmarken 11, 2970 Hørsholm
Agern Alle 24, 2970 Hørsholm
Kogle Alle 2, 2970 Hørsholm

Former names

Afyx Therapeutics A/S – now
Inphena A/S –
Inphena ApS –

Employees per year

Number of employees at Afyx Therapeutics A/S per year112017: 120172018: 12018

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about Afyx Therapeutics A/S

Has Afyx Therapeutics A/S gone bankrupt?

No, Afyx Therapeutics A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Afyx Therapeutics A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the auditor of Afyx Therapeutics A/S?

Afyx Therapeutics A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Afyx Therapeutics A/S founded?

Afyx Therapeutics A/S was founded on 12 July 2017.

What is the equity of Afyx Therapeutics A/S?

Equity was DKK 36.2m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.